The connection between environmental public health regulations, regulatory science, and public health gains can, at times, be difficult to elucidate. Why? Some challenges are raised by the complex mosaic of federal and state regulatory decisions, differences in the implementa tion of those decisions at more local levels, the multiple determinants of disease, and temporal lags between exposure and ultimate health outcomes (National Research Council 2007) . This difficulty in making linkages between regulations and health outcomes often necessitates the choice of indirect measurements of success such as process indica tors (e.g., number of facilities inspected) or emissions indicators (e.g., tonnage of pollutants captured). Such indirect indicators fail to make the necessary connection to human exposure or health outcomes. The challenge remains to make these linkages at the appropriate spatial and temporal scales to bolster the evidence base for environmental decision making [U.S. Environmental Protection Agency (EPA) 2008b] .
Despite these difficulties, it remains incumbent on the environmen tal regulatory community to, where possible, "close the loop" by demon strating that regulations have achieved their intent. Developing ways to better understand the impact of regulations and policies is essential, and in the long run will help regulators to predict the public health impacts of incremental or major changes in regulatory actions that affect envi ronmental exposures (U.S. EPA 2007). This is a critical step in ensuring that the actions taken and resources spent by governments, the regulated community, and others are protecting public health. Further, it helps to identify where continued improvements could be made.
One notable area where the linkage between regulation and health outcomes has been made is in lead abatement. Figure 1 provides a concise view of how actions promulgated to reduce lead exposure can be arrayed across a hierarchy of indicators, making the necessary con nections between rules, actions, and outcomes that are necessary to evaluate results and plan next steps. Gaps in this chain that still existed in the 1970s, such as the relationship between air lead and blood lead, presented considerable obstacles to the promulgation of the healthbased regulation limiting lead content of gasoline (Bridbord and Hanson 2009) . That these link ages can now be made is testament to both the magnitude and ubiquity of the problem of lead contamination, the broad engagement of the scientific community over decades of research, and excellent planning to evaluate the outcomes of lead mitigation (e.g., Galke et al. 2005) . Bridbord and Hanson's (2009) narrative makes the important point that taking the lead out of gasoline has made possible further examination of the health effects of lower and lower levels of lead contamination, an example of where following up on the outcomes of regulatory activities has identified opportunities for further risk miti gation and public health promotion.
In the July 2009 issue of Environmental Health Perspectives, Gould (2009) used data accumulated over the past decade on the linkage between environmental lead exposures and health effects to present a compelling description of the potential costs and benefits of lead hazard control, concentrating on the residential lead paint hazard. In her analysis, Gould incorporated certain health, social, and behavioral costs and ben efits left out of earlier valuation analyses associated with lead (President's Task Force 2000; U.S. EPA 2008a, 2008c) arguing, in effect, that these data have reached a level of maturity that permits their inclusion.
Gould had good reason for concentrating on lead paint for her analysis; 25% of the nation's housing has significant hazards from leadbased paint in the form of deteriorated paint, dust lead, or bare soil lead (Jacobs et al. 2002) . Abatement is a good indicator of success. The accumulated evidence is clear: Abatement reduces dustlead load ings when measured as far out as 3 years after treatment (Dixon et al. 2005) . This abatement results in decreases in whole blood lead levels of approximately 20-26% within a year for population samples of chil dren with pre abate ment levels just above the current intervention level (geometric mean, 11 µg/dL; Galke et al. 2001 ) and at higher levels (23 µg/dL; Taha et al. 1999) . A 333
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Moreover, some analyses (e.g., Nriagu et al. 2006) suggest that the remaining problem of lead contamination is likely associated with the presence of peeling paint and cracked walls in housing rather than with variables associated with water use or potential air exposure. This applies even in an urban system with lead present in the water distribution system or with proximity to possible outdoor sources of lead contamina tion such as factories, incinerators, repair shops, or gas stations.
Gould's focus on paint hazard (Gould 2009 ) highlights the dra matic decrease in the level of lead exposure and associated biomarker levels due to the reduction of lead content in gasoline, household paint, industrial emissions, drinking water, food canning, and ceramic glazes. It also acknowledges, however, that a large problem remains. In Milwaukee, Wisconsin, for example, 15.7% of children living in neigh borhoods surrounding a former industrial corridor have blood lead levels ≥ 10 µg/dL [Agency for Toxic Substances and Disease Registry (ATSDR) 2008]. These children and others in lead exposure hot spots have not fully shared the bene fits of the regulatory and mitigation actions that have brought the national average down to 1.5 µg/dL (U.S. EPA 2008b). The magnitude of this problem remains a public health challenge, and the associated lead exposure hazard is an obstacle to the revitalization of America's cities and communities.
U.S. EPA Administrator Lisa Jackson has commented on a number of occasions that science must be the determining factor in making decisions that affect the environmental health of America's communities, that the determinations and process of our decisions must be transparent, and that eliminating disparities in the environ mental health of America's communities must be paramount (Jackson 2009a (Jackson , 2009b (Jackson , 2009c . The analysis by Gould (2009) offers an oppor tunity in all of these areas by bringing a broad consideration of pub licly available medical, economic, and social sciences to bear on the welldeveloped understanding of the sources and routes of lead expo sure. Further, Gould identifies and quantifies the costs and benefits of closing the book on a major remaining facet of our nation's lead problem. In a real sense, she offers lead abatement as an example of a "green economy" for which modest investment can reap great returns. She also points to the importance, at this time, of considering the nation's environmental health issues in a placebased context, show ing that while dramatic, initial environmental health gains have been made based on sectorbased banning of lead from consumer products and through air and water regulation, the public health and economi cally critical increments that remain will need to be addressed through placebased targeting for a burden that disproportionately affects resi dents with lower socio economic status.
Even with the inclusion of these additional factors, Gould's esti mate (Gould 2009 ) might still be considered conservative because it concentrates almost wholly on children < 6 years of age. Recent research has identified associations between cumulative lead exposure and cognitive impairment, hypertension, and other health outcomes in older adults NavasAcien et al. 2007; Shih et al. 2007 ). These adverse outcomes are worsened by coexposure to stress, including neighborhood psycho social hazards (Glass et al. 2009; Peters et al 2007; cf. Gump et al. 2008) . Although much of the research on older adults has focused on lead accumulated and stored in bone dur ing the lifetime, questions still remain about the role of concurrent exposure to lead from housing stock or other sources (Lin et al. 2004 ).
Most older Americans age in place, with 29% of adults > 65 years of age living in housing stock built in 1949 or ear lier. This is especially true for urban and rural communities in the Northeast and Midwest regions of the United States, where 40-60% of older adults live in this housing stock (Golant 2008) . Unfortunately, these are also the regions where leadbased paint hazards are most prevalent, particularly in this older housing; 57% of housing built in 1940-1959 and 81% built before 1940 con tain lead hazards (Jacobs et al. 2002) , and risk of lead toxicity for children is highest in these regions, particularly in older housing stock (Bernard and McGeehin 2003) . If the relationship between older housing stock and the percentage of older adults with ele vated blood lead remotely mirrors that in children (Bernard and McGeehin 2003; Sargent et al. 1997) , then the problem of concur rent exposure may indeed be a serious one.
In her analysis, Gould (2009) demonstrated significant benefits to improving public health by lead paint remediation or control, adding an economic basis to the health and exposure data that make a process indicator such as paint hazard abatement a reasonable sur rogate for exposure and health indicators for children. If the linkages found for children also apply to older adults, it will be important to assess whether additional, economically quantifiable benefit can be gained from remedia tion aimed at aging adults, the most rapidly growing portion of the U.S. population.
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Guest Editorial
Adverse gene-environment interactions (G × E) probably influence most chronic diseases, including neurologic disorders and cancer. The genetic (G) contribution to different diseases varies, but several lines of evidence clearly show that non genetic factors have high attribut able risks, often in the range of 80-90% (Willett 2002). The domi nance of non genetic components highlights the importance of the environment (E) to chronic disease risks.
Genomic tools arising from the Human Genome Project (HGP), combined with bioinformatics studies, have allowed epidemiologists to examine the genetic component of chronic diseases. Genomewide association studies offer glimpses of the roles that particular genes play in disease development. However, the genetic factors identified thus far have generally been of low penetrance (a few percent at most) and have mainly offered clues as to which G × E (and G × G) effects might be worth pursuing.
In contrast, the tools for quantitative assessment of exposuresbased on measurements of chemicals in air, water, food, and the human body-have changed little since the 1970s. The lack of highthroughput methods of exposure assessment has motivated epidemiolo gists to rely upon selfreported data to categorize chemical exposures from envi ronmental, endog enous, and dietary sources. With the possible exceptions of smoking and alcohol consumption, such selfreports have been unreliable predictors of longterm exposure lev els and are poorly suited for detecting G × E effects.
Although 30 years of investment in G now illuminates genetic determinants of diseases, we are still in the dark ages when it comes to quantifying E (i.e., human exposures). Recognizing the disparity in current knowledge between genes and environmental exposures, Wild (2005) defined the "exposome," representing all environmental expo sures (including those from diet, lifestyle, and endogenous sources) from conception onward, as a quantity of critical interest to disease etiology. If we expect to have any success at identifying the effects of E, G, and G × E on chronic diseases, we must develop 21stcentury tools to measure exposure levels in human populations. That is, we need an HGPlike commitment to quantify the exposome.
